Molina Healthcare (MOH, Financial) has been downgraded from Outperform to Neutral by Baird analyst Michael Ha. The new price target set for the company is $375, increased from the previous $331. This adjustment reflects Baird's anticipation of limited additional investment interest in the managed care and healthcare facilities sector in the near term.
The firm highlighted ongoing policy uncertainties as a primary influencing factor. Baird does not foresee companies in this sector raising their financial forecasts, suggesting that they might retain a cautious approach for 2025. This conservative stance comes amid potential challenges, particularly from Part D and other macroeconomic pressures that could impact the industry later this year.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 13 analysts, the average target price for Molina Healthcare Inc (MOH, Financial) is $346.58 with a high estimate of $400.00 and a low estimate of $279.00. The average target implies an downside of 0.57% from the current price of $348.57. More detailed estimate data can be found on the Molina Healthcare Inc (MOH) Forecast page.
Based on the consensus recommendation from 17 brokerage firms, Molina Healthcare Inc's (MOH, Financial) average brokerage recommendation is currently 2.6, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Molina Healthcare Inc (MOH, Financial) in one year is $456.52, suggesting a upside of 30.97% from the current price of $348.57. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Molina Healthcare Inc (MOH) Summary page.
